Measure your identity data management maturity. Take our 5-minute maturity assessment now

2024 Gartner® Hype Cycle™ for Real-Time Health System Technologies

/

 

The latest Gartner Hype Cycle for Real-Time Health System Technologies, published July 2024, includes next-generation EMPI technology. While Gartner has currently positioned next generation EMPI at the height of inflated expectations, it is also placed in the high benefit category.

Many organizations are finding quantifiable value from next-generation EMPI solutions in improving patient care, delivering better patient experiences, streamlining M&A, and more. As you determine the right solution to create a 360-degree view of your patients and providers, here is how Verato stacks up against user recommendations from Gartner:

User recommendations Verato has:
Next-generation EMPI-enabling technologies A patented approach to referential matching
Proven experience reconciling person and patient identities in the healthcare sector A cloud-native healthcare MDM (hMDM) platform that was purpose-built for healthcare
Experience in the industry An NPS score in the 99th percentile from a strong healthcare customer base

Download the report and explore the technologies essential to next-generation health systems

 

Gartner Hype Cycle™ for Real-Time Health System Technologies, 2024, Barry Runyon, Gregg Pessin, 8 July 2024. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.